What the Study Found (In Plain English)
Published in The American journal of psychiatry (2004), this randomized controlled trial evaluating 188 human participants investigated: Sertraline's efficacy and tolerability in treating generalized anxiety disorder were evaluated. Key clinical takeaway: Sertraline appears to be efficacious and well tolerated in the treatment of generalized anxiety disorder.
Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers
Primary Endpoint & Quantitative Summary (The American journal of psychiatry, 2004-09-15; N = 188; Rigor 88/100): Sertraline appears to be efficacious and well tolerated in the treatment of generalized anxiety disorder.
Study Limitations & Caveats Before You Act
Clinical trials evaluate specific inclusion/exclusion cohorts under protocol-controlled conditions (Randomized Controlled Trial). Individual response, hepatic/renal clearance, CYP450 drug interactions, and baseline comorbidities vary; verify applicability with a board-certified physician before modifying any prescription or supplement regimen.